Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BGI has established itself as a global leader in genomics with commercialized clinical diagnostic products such as the NIFTY test for non-invasive prenatal screening. It played a key role during the COVID19 pandemic by rapidly developing nucleic acid detection kits and deploying large-scale population testing solutions worldwide. The company also operates one of the world’s largest DNA sequencing facilities and runs China’s National GeneBank DataBase.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BGI.